✦ LIBER ✦

Effects of Extended-release Niacin/Laropiprant on Apolipoprotein B, LDL-Cholesterol, and Non-HDL-cholesterol Targets in Patients with Type 2 Diabetes

✍ Scribed by Joseph Triscari; Erluo Chen; Amy O. Johnson-Levonas; Yale B. Mitchel; Rae Ann Ruck; Alexandra MacLean; Darbie Maccubbin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atorvastatin treatment lowers fasting re

✍ Paul J.W.H. Kappelle; Geesje M. Dallinga-Thie; Robin P.F. Dullaart 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Greater Dissociation of apoB, LDL-C and

✍ Joseph Triscari; Michel Farnier; Erluo Chen; Amy O. Johnson-Levonas; Yale B. Mit 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 42 KB

Mo-P5:309 Influence of BMI and HBA1C on

✍ Disoteo, O.; Pizzi, G.L.; Zanni, D.; Fossati, C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB

P248 INFLUENCE OF FENOFIBRATE, SIMVASTAT

✍ Farnier, M.; Taggart, W.; Dong, Q.; Shah, A.; Brudi, P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Effects of Ezetimibe, Simvastatin, and E

✍ John R. Guyton; Michel Farnier; Erin H. Jensen; Adam B. Polis; Amy O. Johnson-Le 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 58 KB

Effect of age on the association of non-

✍ G. Bruno; F. Merletti; A. Biggeri; G. Bargero; S. Prina-Cerai; G. Pagano; P. Cav 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 114 KB